Clinical Trial

Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

Recruiting
View on ClinicalTrials.gov →
Summary
This specimen collection is designed to obtain whole blood and tumor tissue from subjects diagnosed with cancer for the purpose of the development of a noninvasive liquid biopsy assay using next generation sequencing (NGS).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2015-10-22; most recent amendment 2024-10-11.
Trial Details
NCT Number NCT02586389
Lead Sponsor Sequenom, Inc.
Conditions Non-hematologic Cancer
Enrollment 3,000 participants
Start Date 2015-10-13
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-16